Dublin, Jan. 17, 2022 (GLOBE NEWSWIRE) -- The "Global Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Test, Platform, End User, Application and Country Analysis and Forecast, 2020-2031" report has been added to ResearchAndMarkets.com's offering.
The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61 billion by 2031, registering a CAGR of 15.79% during the forecast period 2021-2031.
Market Dynamics
- Growth Drivers
- Increased Emphasis on Early Detection and Prevention
- Availability of Advanced Screening Technologies
- Increasing Consumer Demand
- Shifting of Reimbursement Policies Toward More Genetics Coverage
- High Incidence Rate of Down's Syndrome
- Rising Average Maternal Age
- Increasing Prevalence of Genetic and Congenital Disorders
- Challenges
- Stringent Regulatory Guidelines and Ethical Hurdles
- Limitations of NIPT
- Lack of Awareness Among Consumers
- Alternative Screening and Testing Methods
- Opportunities
- Capitalizing on the Potential Presented by the Emerging Markets in Asia
- Availability of Direct-to-Consumer Tests
- Focus on Pre-Implantation Genetic Diagnosis
Market Segmentation
- By Test - Panorama and Vistara; MaterniT GENOME, MaterniT 21 PLUS, informaSeq, Verifi and Verifi Plus Prenatal Tests; Harmony Test; NIFTY Test and NIFTY Test Pro; QNatal Advanced; PrenaTest, GeneSafe, and PrenatalSAFE; Bambni Test; IONA and Sage; and Others
- By Platform - PCR, Next-Generation Sequencing, and Others
- By Method - cfDNA and FCMB
- By End User - Hospitals, Clinics, Diagnostic Labs, and Others
- By Application - Trisomy Detection, Microdeletion Detection, Sex Chromosome Aneuploidy Detection, Others
Competitive Landscape
The NIPT market is currently at a blooming phase, with the presence of various juggernauts such as Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Illumina, Inc., Agilent Technologies, Inc., BGI, and PerkinElmer Inc., as well as other medium and small-medium enterprises, that are offering wide range of NIPT products and services in the market. Several companies are attempting to enter the market and sustain themselves in the competition by adopting different strategies varying from partnerships and collaborations to business expansions and product launches.
Companies Profiled
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- PerkinElmer, Inc.
- Quest Diagnostics Incorporated
- Illumina, Inc.
- Myriad Genetics, Inc.
- BGI
- CENTOGENE N.V.
- Laboratory Corporation of America Holdings
- MedGenome Inc.
- Annoroad Gene Technology
- Natera, Inc.
- Yourgene Health PLC
- Next Biosciences
- Eurofins Scientific
Key Questions Answered in the Report
- What is the importance of NIPT, and what are the different NIPT products/services available in the market? What are the different methods of NIPT, and what are the benefits and risks associated with it?
- What are the major technological advancements witnessed by the global NIPT market in the past four years, and what is the future scope of the market? What are the key trends of the global NIPT market as per the year 2020, and how is the market evolving currently?
- What was the market size of the global NIPT market in 2020, and what is the market size anticipated to be in 2031? What is the expected growth rate of the global NIPT market during the period 2021-2031?
- What is the market scenario and growth potential of different regions of the world, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
- What are the major drivers, challenges, and opportunities of the global NIPT market?
- Who are the major key players of the global NIPT market? How much market share does each of these players occupy in the market in 2019? Which companies are anticipated to be highly disruptive in the future, and why?
- What is the regulatory scenario of the global NIPT market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of NIPT products?
- What is the average NIPT cost in different countries? What is the reimbursement scenario of the global NIPT market, and what is the reimbursement rate in different countries of the world, including countries of North America, Latin America, Asia-Pacific, Europe, and the Middle East and Africa?
- What is the funding scenario of the market with respect to institutional and academic funding? What is the patent landscape of the market, and which companies stand out for registering the greatest number of patents?
- What are the key developmental strategies implemented by the key players of the global NIPT market to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
- What are the different NIPT tests available in the market, and which test type dominates the market in 2020 and 2031 in terms of value and volume?
- What is the global market size (by value and volume) of different types of products of the global NIPT market in 2020? What are the key trends of the market with respect to different kits, assays, and which product is expected to dominate the market in 2031?
- What are the different platforms supported by NIPT products? Which technology type dominated the market in 2020 and is expected to dominate in 2031 (by value and volume)?
- What are the different applications associated with NIPT? What was the contribution of each of the application areas in the global NIPT market for the period between 2021 and 2031 (by value and volume)?
- What is the global NIPT market size (by value and volume) based on different methods? Which method is currently leading the market and why? Which method is expected to lead the market during the forecast period?
- Who are the different end users of the global NIPT market (by value and volume)? Which end-user type is the major contributor of revenue in the market?
For more information about this report visit https://www.researchandmarkets.com/r/419u4y
